Clinical Trial Update: Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial at UC San Diego is exploring transdiagnostic cognitive dyscontrol mechanisms across anxiety disorders, depressive disorders, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Depressive Disorders
• Post-traumatic Stress Disorder

Snippet

Sponsor: University of California, San Diego | Conditions: Anxiety Disorders, Depression | Phase 2, Phase 3 | Status: RECRUITING